Moleculin Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 15
Employees
  • Stock Symbol
  • MBRX
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $1.12
  • (As of Thursday Closing)

Moleculin General Information

Description

Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Primary Office
  • 5300 Memorial Drive
  • Suite 950
  • Houston, TX 77007
  • United States
+1 (713) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Moleculin Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.12 $1.14 $0.32 - $1.97 $67.7M 60.4M 4.57M -$0.22

Moleculin Financials Summary

In Thousands,
USD
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 22,092 26,840 19,615 30,577
Revenue 0 0 0 0
EBITDA (10,419) (13,248) (11,812) (9,787)
Net Income (10,372) (13,205) (11,876) (9,805)
Total Assets 25,472 25,235 19,585 19,483
Total Debt 355 379 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Moleculin Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Moleculin‘s full profile, request access.

Request a free trial

Moleculin Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug can
Pharmaceuticals
Houston, TX
15 As of 2020
000.00
000000000 000.00

0000000

m veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis au
000000000000000
Wayne, PA
00 As of 0000
00000
00000000000 00000

0000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolor
000000000000000
The Woodlands, TX
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Moleculin Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aclaris Therapeutics Formerly VC-backed Wayne, PA 00 00000 00000000000 00000
0000000 0000000000 Corporation The Woodlands, TX 000 00000 000000 - 000 00000
00000000 000000000 Corporate Backed or Acquired 000.00 000000&0
000000 Formerly VC-backed Waltham, MA 00 00000 000000000 00000
000000 00000000 Formerly VC-backed Vancouver, Canada 00 000.00 00000000000 000.00
You’re viewing 5 of 12 competitors. Get the full list »

Moleculin Executive Team (8)

Name Title Board Seat Contact Info
Walter Klemp Chief Executive Officer & Chairman
Jonathan Foster Executive Vice President & Chief Financial Officer
Donald Picker Ph.D Chief Scientific Officer
Robert Shepard Chief Medical Officer
Sandra Silberman Ph.D Executive
You’re viewing 5 of 8 executive team members. Get the full list »

Moleculin Board Members (9)

Name Representing Role Since
0. 000000 0000000 00.0 Self Director 000 0000
0000 0000000 00 Self Board Member 000 0000
0000000 000000 Self Board Member 000 0000
0000000 0000000 Self Director 000 0000
000000 000000 Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Moleculin Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Moleculin Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 28-Oct-2015 000000000000000000 Pharmaceuticals 000000 00000
To view Moleculin’s complete acquisitions history, request access »